CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
2.690
-0.510 (-15.94%)
Sep 15, 2026, 4:00 PM EDT - Market closed
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of $586.15 million as of September 15, 2026. Its market cap has increased by 77.73% in one year.
Market Cap
586.15M
Enterprise Value
261.57M
1-Year Change
77.73%
Ranking
Category
Stock Price
$2.69
ChartMarket Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has increased from $7.40M to $586.15M, an increase of 7,820.93%. That is a compound annual growth rate of 49.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 586.15M | -18.79% |
| Dec 31, 2025 | 721.80M | 795.53% |
| Dec 31, 2024 | 80.60M | -22.35% |
| Dec 29, 2023 | 103.80M | -1.80% |
| Dec 30, 2022 | 105.70M | -62.58% |
| Dec 31, 2021 | 282.50M | -6.70% |
| Dec 31, 2020 | 302.80M | -19.81% |
| Dec 31, 2019 | 377.60M | -44.44% |
| Dec 31, 2018 | 679.60M | -16.18% |
| Dec 29, 2017 | 810.80M | 102.65% |
| Dec 30, 2016 | 400.10M | -46.78% |
| Dec 31, 2015 | 751.80M | 10,059.46% |
| Oct 8, 2015 | 7.40M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Altimmune | 628.29M |
| Oculis Holding AG | 621.64M |
| Valneva SE | 617.63M |
| CorMedix | 604.85M |
| Scribe Therapeutics | 599.38M |
| Shattuck Labs | 599.17M |
| AgomAb Therapeutics NV | 598.86M |
| Allogene Therapeutics | 594.24M |